1. Home
  2. CAL vs AUPH Comparison

CAL vs AUPH Comparison

Compare CAL & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Caleres Inc.

CAL

Caleres Inc.

HOLD

Current Price

$12.43

Market Cap

449.1M

ML Signal

HOLD

Logo Aurinia Pharmaceuticals Inc

AUPH

Aurinia Pharmaceuticals Inc

N/A

Current Price

$16.14

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CAL
AUPH
Founded
1878
1993
Country
United States
Canada
Employees
N/A
N/A
Industry
Shoe Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
449.1M
2.1B
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
CAL
AUPH
Price
$12.43
$16.14
Analyst Decision
Buy
Buy
Analyst Count
2
4
Target Price
$15.00
$17.25
AVG Volume (30 Days)
443.9K
1.0M
Earning Date
05-28-2026
05-07-2026
Dividend Yield
2.13%
N/A
EPS Growth
N/A
5075.00
EPS
0.42
0.53
Revenue
$85,513,000.00
$283,055,000.00
Revenue This Year
$5.19
$17.54
Revenue Next Year
$2.45
$15.74
P/E Ratio
$28.93
$30.41
Revenue Growth
0.46
20.38
52 Week Low
$8.80
$10.34
52 Week High
$16.14
$19.25

Technical Indicators

Market Signals
Indicator
CAL
AUPH
Relative Strength Index (RSI) 42.19 51.41
Support Level $12.02 $14.61
Resistance Level $14.04 $16.46
Average True Range (ATR) 0.57 0.47
MACD -0.19 -0.01
Stochastic Oscillator 18.95 38.28

Price Performance

Historical Comparison
CAL
AUPH

About CAL Caleres Inc.

Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - Famous Footwear and Brand Portfolio. The Famous Footwear segment is comprised of its Famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. This segment is comprised of wholesale operations that designs, develops, sources, manufactures, markets and distributes branded, licensed and private-label footwear. Geographically, the company generates the majority of its revenue from Domestic operations.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Share on Social Networks: